In a mansion on a hill with a killer view of Los Angeles, a dozen social media influencers have gathered to bake protein-packed muffins, take selfies with giant injector pens and talk about how Ozempic has changed their lives. Welcome to the GLP-1 hype house, sponsored by WeightWatchers.
The day-long experience was a marketing event for WW International Inc.’s new prescription obesity drug service—possibly the biggest brand shift in the company’s 60-year history. WeightWatchers has been enlisting influencers to “help bust the misconceptions and stigma around GLP-1 medications”—as in weight-loss shots like Wegovy and Zepbound—and to “share that WW is here to support you,” according to an email sent out to multiple potential partners viewed by Bloomberg News.
It didn’t go as planned. A social-media backlash started brewing before the posting even began. Back in December, the company reached out to influencers who post their Ozempic, Wegovy and other weight-loss drug use, asking them to hawk their new service. The anger was twofold: Many of those people had negative associations with the brand’s decades-long approach to food and dieting. A few said WeightWatchers’ points system, which assigns number values to food for optimal nutritional intake, led to their own disordered eating.